A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy

J. Kevin Hicks, Jeffrey R. Bishop, Roseann S. Gammal, Katrin Sangkuhl, Chad A. Bousman, J. Steven Leeder, Adrián Llerena, Daniel J. Mueller, Laura B. Ramsey, Stuart A. Scott, Todd C. Skaar, Kelly E. Caudle, Teri E. Klein, Andrea Gaedigk

Research output: Contribution to journalComment/debatepeer-review

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)50-52
Number of pages3
JournalClinical pharmacology and therapeutics
Volume107
Issue number1
DOIs
StatePublished - Jan 1 2020

Bibliographical note

Funding Information:
J.K.H. is funded by the H. Lee Moffitt Cancer Center & Research Institute (NIH P30-CA076292), OneOme, and the American Society of Health Systems Pharmacists. R.S.G., K.E.C., K.S., and T.E.K. are funded by the National Institutes of Health (NIH) for CPIC (R24GM115264 and U24HG010135). K.S. and T.E.K. are funded by the NIH for PharmGKB (R24GM61374). J.S.L. is funded by grant U54 HD090258 for the Genomic- and Ontogeny-Linked Dose Individualization and Clinical Optimization for Kids from the Eunice Kennedy Shriver National Institute of Children Health and Human Development and the Sarli Family Foundation. L.B.R. is funded by grant R01HD089928 from the Eunice Kennedy Shriver National Institute of Children Health and Human Development. A.G. is funded by the NIH for PharmVar (R24 GM123930).

Cite this